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THIS condition was first reported in Boston in 1942 when Terry (1942), an
ophthalmologist, detected a form of blindness in children which had not hitherto
been described. It occurred only in those children born prematurely and of low
birth weight. Exatination of the eyes showed a white fibrous mass behind the
lens which obliterated the retina-a condition he named "retrolental fibroplasia."
In the following few years, the incidence of this disease increased alarmingly
and many cases were reported from all parts of the United States. The first case
in England was detected in 1946, and by 1950 this disorder had become the
commonest cause of blindness in the pre-school child. For example, in one
maternity hospital three out of every four premature infants below 4 lbs. birth
weight at one period were noted to show evidence of the disease. In Belfast, by
1951, thirteen children blind from this disease had already been seen at the
Royal Belfast Hospital for Sick Children. The full extent of this catastrophe in
Ulster, as elsewhere, is difficult to assess, as additional cases may possibly have
been seen at other eye and children's hospitals or departments.
RECOGNITION.
How can the disease be detected clinically? It is confined to premature infants,
especially those under 4 lbs. weight at birth. The affected infant's eyes appear
normal at birth, but within a few days or weeks the iris becomes injected and the
vitreous slightly hazv. The retinal veins are full and dilated, the arteries tortuous.
(See Fig. 1.) This change is best seen peripherally where new vessels develop,
and haemorrhages may occur. The retina becomes pale and cedematous and later
folded or detached. (See Fig. 2.) Finally, the retina becomes obliterated by a
mass of white fibrous tissue so that, on looking into the eye, only a white reflex
*is seen and little or none of the detail of the retina can be appreciated. Up to the
stage of retinal detachment the changes are reversible and in about half the cases
they regress partially or completely. In the former, pigmentation and scarring
follow, but some useful sight remains. (See Fig. 3.) At the stage of retinal
detachment the changes are permanent and vision is grossly or completely impaired.
The lesion is almost always bilateral; but the severity of the disease is not
necessarily equal in both eyes, for the condition may regress in one eye and progress
to blindness in the other eye. Later, the anterior chamber appears shallow and
the iris grey and atrophic. Microphthalmos, glaucoma, and cataract may ensue.
The pathological changes found in the eye occur principally in the nerve fibre
layer of the retina where there is excessive proliferation of vasoformative tissue.
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FThis may burst through the retinal layer and invade the vitreous; it results in
oedema and hvemorrhage leading to retinal detachment and later fibrosis which
results in the formation of the dense retrolental membrane.
A NEW DISEASE.
Retrospective surveys indicate that retrolental fibroplasia is, in fact, a new
disease, since it was not observed in premature infants born before 1940, nor has it
been seen in children of a similar age group in schools for the blind.
'ETIOLOGY.
Since it is a disease which occurs only in the premature infant, the search for
the rtiology was limited to factors such as prematurity and its causes, or the
management and environment of the infant in the early weeks of its life.
Investigation had shown that no factor such as parity, maternal age, maternal
TABLE 1.
RELATION OF BIRTH WEIGHT AND INCIDENCE OF RETROLENTAL FIBROPLASIA.
M.R.C. (1955).
Incidence of Retrolental
No. of Infants Birth Weight Fibroplasia (per cent.)
61 ... Under 21 lbs. ... 16.4
152 ... 2212-3 ,,... 15.8
298 ... 3 -31 ,, ... 11.7
580 ... 3J-4 ,, ... 2.6
TOTAL, 1,091 4 omitted with congenital cataracts.
disease or anaesthetic agent could be incriminated. Likewise, there was no
evidence that a toxic element in the diet, whether breast or artificial feeding, or
in the dietary supplements such as iron, vitamins A and D, or C, given to the
infant was responsible. There was no association found between retrolental
fibroplasia and other angiomatous conditions such as skin noevi, or with exposure
to light or with ultra violet irradiation.
THE R6LE OF OXYGEN.
By 1950 most of these theories had been investigated and excluded and a most
promising clue was being followed up. Was retrolental fibroplasia due to the
increasing use of oxygen in the management of the premature infant? For example,
Crosse (1952) had observed that reducing the duration of oxygen treatment had
lowered the incidence of retrolental fibroplasia. She also noted that the disease
occurred particularly in those premature baby units in modern hospitals in the
United States where oxygen was used extensively. Campbell (1951), in Melbourne,
had also noted that more cases of retrolental fibroplasia occurred in premature
infants in one maternity unit where high concentrations of oxygen were used,
but fewer cases occurred in two other hospitals where little oxygen and lower
concentrations were available.
If oxygen is the causative agent, how could this be safely proved?
14CLINICAL EVIDENCE.
In 1951 the Medical Research Council organised an extensive clinical investigation
in seventeen maternity hospitals in the United Kingdom, including the Royal
Maternity Hospital, Belfast. One thousand nine hundred and ninety-nine premature
infants of less than 4 lbs. birth weight were observed and of one thousand and
ninety-five who survived for at least two months, eighty-four (7.7 per cent.)
developed retrolental fibroplasia, forty-five (4.2 per cent.) progressing to blindness.
The Medical Research Council's report (1955) showed that retrolental fibroplasia
occurred almost exclusively in premature infants below 4 lbs. in weight and that
the incidence of retrolental fibroplasia rose progressivly as the birth weight fell
(Table 1). The condition only occurred when oxygen was given and that the longer
oxygen was administered the more likely was retrolental fibroplasia to develop
(Table 2).
TABLE 2.
INCIDENCE OF RETROLENTAL FIBROPLASIA IN RELATION TO
DURATION OF OXYGEN TREATMENT.
M.R.C. (1955).
No. of No. of Days CASES OF RETROLENTAL FIBROPLASIA Total per cent.
Infants in Oxygen Blind Regressed Incidence
344 ...
237 ... > 5 ... 1 ... 1 0.8
230 ... 5-10 ... 5 ... 8 ... 5.7
214 ... 11-30 25 ... 16 ... 19.2
40 ... < 31 ... 11 ... 13 ... 60.0
Between October, 1951, and May, 1953, of one hundred and nine premature
infants who survived at the Royal Maternity Hospital, eleven showed evidence of
retrolental fibroplasia; in four of these the changes regressed, but in seven blindness
developed in one or both eyes.
This 10 per cent. incidence of retrolental fibroplasia at the Royal Maternity
Hospital represented the fifth highest in the seventeen hospitals in the Medical
Research Council investigation. There are at least three reasons for this apparently
high figure. Firstly, every surviving infant was successfully followed up, and it
is most unlikely that a single case of retrolental fibroplasia in the Royal Maternity
Hospital survey escaped detection. Secondly, and most important, the overall
survival rate-67 per cent. of premature infants below 4 lbs. birth weight-was
the highest of the seventeen hospitals in the trial. Thirdly, a few of the English
maternity units were aware of the possible association of oxygen and retrolental
fibroplasia somewhat earlier in the trial. Since 1952,. when lower concentrations
of oxygen have been in use at the Royal Maternity Hospital, the incidence of
retrolental fibroplasia fell immediately, and from June, 1953, there have only been
two definite and one doubtful cases of retrolental fibroplasia, all of which regressed
before the stage of retinal detachment, and so blindness has not developed. In
1955 there have not been any examples of the disease.
15The importance of oxygen has also been shown by Boyd and Hunt (1955) in a
survey of all premature infants born in England and Wales in 1951. This revealed
an incidence of 2.1 per cent. of retrolental fibroplasia in premature infants born in,
or transferred to hospital, whereas no case of retrolental fiboplasia occurred in
prernature infants reared at home, presumably without oxygen therapy.
EXPERIMENTAL EVIDENCE.
That oxygen is an important, if not the sole agent causing this form of blindness
in premature infants has been confirmed by the experimental work of Ashton and
his colleagues at the Institute of Ophthalmology (1953 and 1954).
These workers noted that kittens' eyes at birth are at a similar stage-of develop-
ment as those of the small premature infant and became mature about three weeks
after birth. They showed histologically that a marked constriction of the retinal
vessels resulted when the newborn kittens were reared in high concentrations of
oxygen. This constriction affected the arteries especially, beginning in less than
twelve hours and going on to complete obliteration of the vessels after about
thirtv-six hours in a concentration of 70-80 per cent. of oxygen. The degree of
vasoconstriction varied with the duration and concentration of oxygen used and
the immaturity of the kittens' eyes, i.e., a 35 per cent. concentration of oxygen
did not produce any constrictive effect regardless of the duration of treatment.
After three weeks of age no change could be induced in the kittens'- eyes with high
concentrations of oxygen.
After a high oxygen concentration had produced a vasoconstriction of the retinal
vessels-the exposure of the kittens to air again resulted in a new development. A
revascularisation of the retina began, the constricted vessels reopened, filled with
blood, the pattern being now grossly abnormal and irregular. Hamorrhage and
retinal detachment followed rupture of the vessels, exactly the pattern that is seen
in the early stages of retrolental fibroplasia in the premature inf-ant.
Using the limbal window technique, Ashton and Cooke (1954) have observed and
recorded cinematographically the actual changes in the retinal vessels, how, when
the newborn kitten is placed in 80 per cent. concentration of oxygen, the retinal
vessels become constricted and even obliterated in as short a time as eight hours.
These vascular changes do not occur, however, in the vessels of the brain or other
parns of the body.
There is, thus, experimental and clinical evidence to show that retrolental
fibroplasia is liable to occur in premature infants, particularly in those below
4 lbs. in birth weight when kept in a high concentration of oxygen for a prolonged
time.
TREATMENT AND PREVENTION.
Knowing now how the blindness develops, what can be done for the victim?
In a condition in which spontaneous remission may occur the effect of therapy is
difficult to assess. Adrenocorticotrophic hormone (A.C.T.H.) and adrenocortical
steroid, e.g., cortisone, have been advocated, but there is no defini-te evidence to
confirm their efficacy, and death has resulted in the premature infant as a result
of such therapy. Likewise, vasodilators, such as tolazoline hydrochloride (Priscol),
16have been tried but without effect. So far there is no effective therapy in the
reversible stage and once retinal detachment has occurred the blindness which
results is permanent.
How, therefore, can premature infants be protected from this tragic form of
blindness?
Prevention of this disease is possible, urgent, and imperative.
At the Royal Maternity Hospital the following precautions are taken. Oxygen
is not given to premature infants as a routine but only when indicated for feeble
respiratory movements, cyanosis, apncea, etc. Oxygen is used for as short a period
as possible, usually one to four days, the concentration of oxygen is checked
daily for individual incubators or boxes, using the Oxygenaire pyrogallic acid
oxygen analyser, and the level is recorded for each premature infant receiving
oxygen. For everyday use, a concentration of 40 per cent. of oxygen is not
exceeded, this being obtained by a flow of not more than 2 litres per minute,
as recorded by the flowmeter for the Oxygenaire type incubator, or 1 litres per
minute for the Queen Charlotte's Hospital canopy-type incubator. The oxygen
concentration is reduced slowly by opening progressively the air vent on the
Oxvgenaire incubator or by propping open the lid of the Queen Charlotte's Hospital
box with wooden pegs increasing in size from i in. to 41 ins. There is a piped
oxygen supply to the premature infant nursery which is controlled by float-type
flowmeters permanently fixed to the walls which prevents the possibility of tilting
or damage when attached to or detached from the oxygen cylinder.
The eyes of all premature infants who weigh less than 41 lbs. at birth are
examined as soon as the individual infant is fit enough. One drop of 1 per cent,
homatropine solution is put in each eye one and a half hours and half an hour
before the examination which is made at weekly or fortnightly intervals or more
frequently if indicated. Special miniature lid retractors, made by Weiss Ltd.,
facilitate the examination.
THE INFLUENCE OF OXYGEN THERAPY ON SURVIVAL RATE.
Is retrolental fibroplasia, which is a man-made disease with the premature infant
as the victim and oxygen as the weapon, the price to be paid to lower the mortality
from prematurity? Since oxygen has been used as a valuable ally in the fight to
save the premature infant, but is now regarded as a dangerous drug in high
concentrations and for prolonged use, is there any evidence to show that these
higher concentrations and longer duration of therapy do, in fact, increase the
survival rate of the premature infant? In the Medical Research Council report it
was concluded that, though there were many other variables to be taken into
account, the nurseries in which'little oxygen was given and which were free from
cases of retrolental fibroplasia did not, on the average, experience survival rates
inferior to nurseries using more oxygen. It is interesting to compare the survival
rat.:s of premature infants over the past twenty years at the Royal Maternity
Hospital, Belfast. In the four years, 1932-1935, every premature infant under
3 lbs. birth weight died, whereas the overall survival rate up to 51 lbs. birth weight
was 64 per cent. By 1947, 21 per cent. of infants under 3 lbs. birth weight survived
17and the overall survival rate had risen to 74 per cent. In 1952, during the early
part of the Medical Research Council investigation, when the use of oxygen was
unrestricted, 55 per cent. of the infants under 3 lbs. survived, while the overall
survival rate was 84 per cent. But in 1954 only 23 per cent. of infants under 3 lbs.
survived, while the overall survival rate had also fallen to 80 per cent. (Table 3).
TABLE 3.
PER CENT. SURVIVAL OF PREMATURE INFANTS AT
ROYAL MATERNITY HOSPITAL, BELFAST.
BIRTH WEIGHT IN
3-3.7 3.8-3.15
56 76
63 ... 80 ...
68 ... 91
59 ... 88 ...
LBS. AND OZS.
44.7 4.8-4.15
72 83
72 79
80 95
87 93
The only major change made in the management of the premature infant at this
time was a reduction in the duration of oxygen administration and careful control
of its concentration.
Can the decrease in the survival rate in the smaller premature infants in 1954
be due to the use of lower concentrations of oxygen, as the survival rate in the
higher birth weight groups of premature infants in 1954 was the same as the 1952
level?
TABLE 4.
FATE OF PREMATURE INFANT BELOW 3 LBS. BIRTH WEIGHT AT THE
ROYAL MATERNITY HOSPITAL, BELFAST, IN 1952 AND 1954.
1952-Period of unlimited oxygen
therapy:
1954-Period of restricted oxygen
therapy:
Alive
Dead
NUMBER OF INFANTS
Birth Weight
lbs. ozs. lbs. lbs. ozs. Total
> 1 15 2 2 15
22 ... 22
- 7 ... *11 ... 18
Alive - - ... 7
Dead - 6 ... *17
*Includes one infant born with congenital malformations incompatible
Per cent.
Surviving
... 55
.. .
... 7 ... 23
... 23 ... -
with prolonged survival.
To eliminate three possible variables in these groups the following analysis
shows that the number of cases and birth weight distribution are roughly the same
for premature infants under 3 lbs. in 1952 and 1954, and also that there is the
same number of congenital abnormalities incompatible with prolonged survival
(Table 4). This suggests that at the Royal Maternity Hospital the use of higher
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1932-5
1947
1952
1954
> 2.15
0
21
55
23
5-5.8
82
96
98
98
Average
Survival
(per cent.)
... 64
... 74
... 84
... 80RETROLENTAL FIBROPLAS IA
Fig. 1-Fundus at 32 weeks. Fig. 2-Fundus at 13 weeks.
Fig. 3-Fundus at 21 weeks.
Reproduced from "British Journal of Ophthalmology," Vol. 56, page 281, 1952.concentrations of oxygen over prolonged periods in 1952 may have been a factor
improving the survival rate for the smaller premature infant. However, the
definite risk of causing blindness in a premature infant when using high oxygen
concentrations far outweighs the possibility of a slightly higher survival rate in
the small premature infants, and the use and concentration of oxygen must continue
to be carefully controlled in the treatment of the premature infant.
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